These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16492882)

  • 21. Cystic fibrosis newborn screening: shifting the key question from "should we screen?" to "how should we screen?".
    Farrell PM
    Pediatrics; 2004 Jun; 113(6):1811-2. PubMed ID: 15173512
    [No Abstract]   [Full Text] [Related]  

  • 22. Newborn Screening for Cystic Fibrosis in California.
    Kharrazi M; Yang J; Bishop T; Lessing S; Young S; Graham S; Pearl M; Chow H; Ho T; Currier R; Gaffney L; Feuchtbaum L;
    Pediatrics; 2015 Dec; 136(6):1062-72. PubMed ID: 26574590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Positive neonatal screening for cystic fibrosis in neonates with renal failure.
    Oosterveld MJ; Schilperoort JV; Lilien MR; Arets HG
    Thorax; 2010 Jul; 65(7):652-3. PubMed ID: 20627926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Positive Newborn Screening for Cystic Fibrosis, What to Do Next?
    Kumar P; Goyal JP
    Indian J Pediatr; 2019 Dec; 86(12):1147. PubMed ID: 31325101
    [No Abstract]   [Full Text] [Related]  

  • 25. Improving outcomes for Colorado's IRT-IRT-DNA cystic fibrosis newborn screening algorithm by implementing floating cutoffs.
    Martiniano SL; Croak K; Bonn G; Sontag MK; Sagel SD
    Mol Genet Metab; 2021; 134(1-2):65-67. PubMed ID: 34489170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thirty-years of screening for cystic fibrosis in East Anglia.
    Calvin J; Hogg SL; McShane D; McAuley SA; Iles R; Ross-Russell R; MacLean FM; Heeley ME; Heeley AF;
    Arch Dis Child; 2012 Dec; 97(12):1043-7. PubMed ID: 23076339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Newborn screening for cystic fibrosis in Serbia: a pilot study.
    Radivojevic D; Sovtic A; Minic P; Grkovic S; Guc-Scekic M; Lalic T; Miskovic M
    Pediatr Int; 2013 Apr; 55(2):181-4. PubMed ID: 23163630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness of newborn screening for cystic fibrosis determined with real-life data.
    van der Ploeg CP; van den Akker-van Marle ME; Vernooij-van Langen AM; Elvers LH; Gille JJ; Verkerk PH; Dankert-Roelse JE;
    J Cyst Fibros; 2015 Mar; 14(2):194-202. PubMed ID: 25213034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood concentrations of pancreatitis associated protein in neonates: relevance to neonatal screening for cystic fibrosis.
    Sarles J; Barthellemy S; Férec C; Iovanna J; Roussey M; Farriaux JP; Toutain A; Berthelot J; Maurin N; Codet JP; Berthézène P; Dagorn JC
    Arch Dis Child Fetal Neonatal Ed; 1999 Mar; 80(2):F118-22. PubMed ID: 10325788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison between two newborn screening strategies for cystic fibrosis in Argentina: IRT/IRT versus IRT/PAP.
    Teper A; Smithuis F; Rodríguez V; Salvaggio O; Maccallini G; Aranda C; Lubovich S; Zaragoza S; García-Bournissen F
    Pediatr Pulmonol; 2021 Jan; 56(1):113-119. PubMed ID: 33095477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Newborn screening for cystic fibrosis in Wisconsin: nine-year experience with routine trypsinogen/DNA testing.
    Rock MJ; Hoffman G; Laessig RH; Kopish GJ; Litsheim TJ; Farrell PM
    J Pediatr; 2005 Sep; 147(3 Suppl):S73-7. PubMed ID: 16202788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic dilemmas resulting from the immunoreactive trypsinogen/DNA cystic fibrosis newborn screening algorithm.
    Parad RB; Comeau AM
    J Pediatr; 2005 Sep; 147(3 Suppl):S78-82. PubMed ID: 16202789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Newborn screening and carrier screening for cystic fibrosis: alternative or complementary?
    Castellani C; Massie J
    Eur Respir J; 2014 Jan; 43(1):20-3. PubMed ID: 24381320
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunoreactive Trypsinogen (IRT) as a Biomarker for Cystic Fibrosis: challenges in newborn dried blood spot screening.
    Therrell BL; Hannon WH; Hoffman G; Ojodu J; Farrell PM
    Mol Genet Metab; 2012 May; 106(1):1-6. PubMed ID: 22425451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pilot study for cystic fibrosis neonatal screening: the Cuban experience.
    Castells EM; Sánchez A; Frómeta A; Mokdse Y; Ozunas N; Licourt T; Arteaga AL; Silva E; Collazo T; Rodríguez F; Martín O; Espinosa M; Del Río L; Pérez PL; Morejón G; Almira C; Núñez Z; Melchor A; González EC
    Clin Chem Lab Med; 2020 Oct; 58(11):1857-1864. PubMed ID: 32352395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel strategies in newborn screening for cystic fibrosis: a prospective controlled study.
    Vernooij-van Langen AM; Loeber JG; Elvers B; Triepels RH; Gille JJ; Van der Ploeg CP; Reijntjens S; Dompeling E; Dankert-Roelse JE;
    Thorax; 2012 Apr; 67(4):289-95. PubMed ID: 22271776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosing cystic fibrosis in newborn screening in Poland - 15 years of experience.
    Sands D; Zybert K; Mierzejewska E; Ołtarzewski M
    Dev Period Med; 2015; 19(1):16-24. PubMed ID: 26003066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emerging issues in cystic fibrosis newborn screening.
    Castellani C; Massie J
    Curr Opin Pulm Med; 2010 Nov; 16(6):584-90. PubMed ID: 20814308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A decision-tree approach to cost comparison of newborn screening strategies for cystic fibrosis.
    Wells J; Rosenberg M; Hoffman G; Anstead M; Farrell PM
    Pediatrics; 2012 Feb; 129(2):e339-47. PubMed ID: 22291119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Neonatal screening for cystic fibrosis].
    Tellería Orriols JJ; Alonso Ramos MJ; Garrote Adrados JA; Fernández Carvajal I; Blanco Quirós A
    An Esp Pediatr; 2002 Jul; 57(1):60-5. PubMed ID: 12139895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.